Kaleido Stock Valuation

KLDO -  USA Stock  

USD 5.67  0.52  8.40%

What is the current enterprise value of Kaleido Biosciences? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Kaleido Biosciences, is its stock price multiplied by the total number of shares outstanding, calculating Kaleido Biosciences' enterprise value requires a different approach. It uses Kaleido Biosciences' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Tangible Asset Value is expected to rise to about 68.5 M this year, although the value of Free Cash Flow will most likely fall to (70.7 M).
Kaleido Biosciences secures a last-minute Real Value of $7.8 per share. The latest price of the firm is $5.67. At this time, the firm appears to be undervalued. Our model forecasts the value of Kaleido Biosciences from analyzing the firm fundamentals such as Shares Owned by Insiders of 3.91 %, current valuation of 226.04 M, and Return On Equity of (161.51) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Search Valuation 

 
Refresh
Kaleido Biosciences Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Kaleido Biosciences's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
5.67
24th of July 2021
Share
Kaleido Biosciences is moderately volatile asset. Calculation of real value of Kaleido Biosciences is based on 3 months time horizon. Increasing Kaleido Biosciences time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Our valuation method for Kaleido Biosciences is useful when determining the fair value of the Kaleido stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Kaleido Biosciences. Since Kaleido Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kaleido Stock. However, Kaleido Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
7.80
Real Value
13.20
Upside
Estimating the potential upside or downside of Kaleido Biosciences helps investors to forecast how Kaleido stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kaleido Biosciences more accurately as focusing exclusively on Kaleido Biosciences' fundamentals will not take into account other important factors:
Earnings
Estimates (4)
LowProjected EPSHigh
-2.66-2.38-2.22
Details
Hype
Prediction
LowEstimated ValueHigh
0.285.6811.08
Details
Naive
Forecast
LowNext ValueHigh
0.14.9110.31
Details
5 Analysts
Consensus
LowTarget PriceHigh
5.0014.6022.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. Some money managers use Kaleido Biosciences' intrinsic value based on its ongoing forecasts of Kaleido Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by look to relative valuation against Kaleido Biosciences' closest peers. When choosing a valuation method Kaleido Biosciences, make sure it is appropriate for the firm given its current financial situation and market classification. If more than one is valuation category is appropriate, we suggest using both methods to arrive at a better estimate.

Kaleido Valuation Drivers Correlation

Many accounts on the financial statements of Kaleido Biosciences are highly interrelated and sometimes correlated. Consequently, when conducting Kaleido's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Kaleido
Click cells to compare fundamentals

Kaleido Market Cap

Kaleido Biosciences is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 1.43 Billion. Kaleido Biosciences totals roughly 316.76 Million in market capitalization claiming about 22% of stocks in Biotechnology industry.
Capitalization  Revenue  Valuation  Total debt  Workforce

Kaleido Biosciences Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Kaleido Biosciences's current stock value. Our valuation model uses many indicators to compare Kaleido Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kaleido Biosciences competition to find correlations between indicators driving Kaleido Biosciences's intrinsic value. More Info.
Kaleido Biosciences is currently regarded as number one stock in price to sales category among related companies. It is currently regarded as number one stock in price to earning category among related companies . . The value of Price to Earnings Ratio is estimated to slide to -4.03. The value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to slide to about (83.1 M)

About Kaleido Biosciences Valuation

The equity valuation mechanism determines the current worth of Kaleido Biosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Kaleido Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kaleido Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Kaleido Biosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Kaleido Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kaleido Biosciences. We calculate exposure to Kaleido Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kaleido Biosciences's related companies.
Last ReportedProjected for 2021
Gross Profit877.5 K872.4 K
Profit Margin(75.34) (81.29) 
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.

Kaleido Biosciences Quarterly Enterprise Value

316.61 MillionShare

Kaleido Biosciences Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Kaleido Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio7.18
Enterprise Value To Ebitda-2.82
Enterprise Value To Revenue177.70

Kaleido Biosciences Current Valuation Indicators

Valuation refers to the process of determining the present value of Kaleido Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Kaleido we look at many different elements of the entity such as Kaleido's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Please see Stocks Correlation. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.